You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Colorcon
Moodys
McKesson
Harvard Business School

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Litigation Details for Steyr Arms Inc v. Beretta USA Corp (N.D. Ala. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Steyr Arms Inc v. Beretta USA Corp (N.D. Ala. 2015)

Docket   Start Trial Date Filed 2015-09-29
Court District Court, N.D. Alabama Date Terminated
Cause 28:1338 Patent Infringement Assigned To Madeline Hughes Haikala
Jury Demand Both Referred To
Parties BERETTA USA CORP; STEYR ARMS INC
Patents 10,001,469; 10,010,260; 10,071,051; 10,072,301; 10,086,047; 10,174,017; 10,174,053; 10,174,073; 10,208,073; 6,027,469; 6,031,301; 6,297,014; 6,469,030; 6,512,072; 7,038,071; 7,045,145; 7,053,212; 7,145,036; 7,260,062; 7,301,023; 7,408,018; 7,408,024; 8,022,064; 8,030,064; 8,030,297; 8,048,017; 8,067,025; 8,512,174; 8,512,297; 8,669,051; 9,020,056; 9,035,033; 9,050,297; 9,051,260; 9,056,051; 9,056,052; 9,061,003; 9,061,005; 9,061,052; 9,061,064; 9,067,112; 9,072,744; 9,297,013; 9,669,008; 9,669,009; 9,669,023; 9,669,024; 9,669,026; 9,669,068
Attorneys Cole Robinson Gresham; Glenn T Henneberger; Jay M Ezelle; Jeffrey D Dyess; John P Luther; Michael Alexander Cornman
Firms Bradley Arant Boult Cummings LLP; Hoffman & Barron LLP; Ladas & Parry LLP; Starnes Davis Florie LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Steyr Arms Inc v. Beretta USA Corp

Details for Steyr Arms Inc v. Beretta USA Corp (N.D. Ala. 2015)

Date Filed Document No. Description Snippet Link To Document
2020-05-28 86 Composed Of Plastic” (“the ’301 Patent”). (Doc. 1, ¶ 7; Doc. 1-1, p. 1). Steyr and Beretta have filed … infringes Claim 1 of the ’301 Patent. Like the pistol described in the ’301 Patent, the Pico utilizes…limitations covered by Claim 1 of the ’301 Patent as construed by the Court: (1) “means for supporting the… the multifunction part (10)” in the Court’s construction of the ’301 Patent. (Doc. 64, pp. 16, 18–20… invention in the ’301 Patent, which provides that “[t]he multifunction part 10 can be produced in various External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
AstraZeneca
Colorcon
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.